New drug approved for irritable bowel syndrome in women.
D003967:Diarrhea / Q000139:chemically induced; D005260:Female; D005765:Gastrointestinal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D007211:Indoles / Q000009:adverse effects / Q000627:therapeutic use*; D043183:Irritable Bowel Syndrome / Q000188:drug therapy*
D005765:Gastrointestinal Agents; D007211:Indoles; C105050:tegaserod